Print Preview

HLA B 27 disease association-13340

Test info

Test name:

HLA B 27 disease association

Test number:

13340

Excellian order number:

LAB13340

Abbreviation:

B27

Alternate names:

B27 Disease Association
HLA Antigen B27
Ankylosing spondylitis
Reactive arthritis
Uveitis

Useful for:

Evaluate spondyloarthritis and other disorders associated with HLA-B27.

Specimen

Specimen type:

EDTA whole blood

Collection container:

Lavender (EDTA), 4mL

Volume:

4.0 mL

Minimum volume:

0.5 mL

Collection instructions:

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

Transport container:

Lavender (EDTA), 4mL

Required forms/information:

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

Transport and stability:

Ambient

Reason for rejection:

Hemolysis
Clotted specimen
Tubes other than lavender-top (EDTA) tube

Performance

Performing lab:

LabCorp Burlington DNA (006924): R-LC

Days set up:

Mo - Sa

TAT:

4 - 7 days

Method:

Polymerase chain reaction (PCR)/sequence-specific oligonucleotide probes (SSOP)

Clinical and Interpretive info

Reference ranges:

The generic sequence coding for HLA-B27 is probed and reported as either P (positive) if it is present, or N (negative) if it is absent

Billing

Preauthorization:

This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.

CPT codes:

81374

Subject to medical necessity (Y/N):

Yes

LOINC code:

Result 26043-0

Other billing information:

Medical necessity

Molecular Medicare billing request

Tracking

Date created:

04/08/2019

Revised date:

05/15/2024

Review date:

07/12/2023